Correction to: Efficacy and Safety of Biosimilar Romiplostim Versus Innovator Romiplostim in Patients with Chronic Immune Thrombocytopenia

Affiliations

• ¹ Seth G. S. Medical College and KEM Hospital, Mumbai, India.
• ² Ishwar Institute of Health Care, Aurangabad, India.
• ³ Nirmal Hospital Pvt Ltd, Surat, India.
• ⁴ LTMMC and General Hospital, Sion, India.
• ⁵ Amrita Institute of Medical Sciences, Kochi, India.
• ⁶ Postgraduate Institute of Medical Education and Research, Chandigarh, India.
• ⁷ Kasturba Medical College (KMC) Hospital, Mangalore, India.
• ⁸ Criticare Hospital and Research Institute, Nagpur, India.
• ⁹ Hemato-Oncology Clinic, Ahmedabad, India.
• ¹⁰ Sahyadri Super Specialty Hospital, Pune, India.
• ¹¹ Meenakshi Mission Hospital and Research Centre, Madurai, India.
• ¹² Grant Medical Foundation Ruby Hall Clinic, Pune, India.
• ¹³ Medical Affairs Department, Alkem Laboratories Limited, Alkem House, Senapati Bapat Marg, Lower Parel, Mumbai, India.